BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16996239)

  • 1. Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy.
    Caracò C; Marone U; Botti G; Celentano E; Lastoria S; Mozzillo N
    Eur J Surg Oncol; 2006 Nov; 32(9):970-3. PubMed ID: 16996239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma.
    Caracò C; Marone U; Celentano E; Botti G; Mozzillo N
    Ann Surg Oncol; 2007 Sep; 14(9):2662-7. PubMed ID: 17597345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node biopsy in patients with cutaneous melanoma: outcome after 3-year follow-up.
    Mozzillo N; Caracò C; Chiofalo MG; Celentano E; Lastoria S; Botti G; Ascierto PA
    Eur J Surg Oncol; 2004 May; 30(4):440-3. PubMed ID: 15063899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis.
    Livestro DP; Kaine EM; Michaelson JS; Mihm MC; Haluska FG; Muzikansky A; Sober AJ; Tanabe KK
    Cancer; 2007 Aug; 110(3):614-24. PubMed ID: 17577228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center.
    Sassen S; Shaw HM; Colman MH; Scolyer RA; Thompson JF
    Ann Surg Oncol; 2008 Feb; 15(2):630-7. PubMed ID: 18080717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy.
    Dalal KM; Patel A; Brady MS; Jaques DP; Coit DG
    Ann Surg Oncol; 2007 Jun; 14(6):1934-42. PubMed ID: 17406951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy in cutaneous melanoma: outcome after 5-years follow-up.
    Cuchet E; Pinel N; Corcella D; Vuillez JP; Lebeau J; Moutet F; Colonna M; Leccia MT
    Eur J Dermatol; 2007; 17(5):387-91. PubMed ID: 17673381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy in elderly irish patients with malignant melanoma.
    Moran DE; Smith MJ; O'Sullivan MJ; Bannon H; Crotty TB; Collins CD; Skehan SJ; O'Higgins N; McDermott EW; Evoy D; Hill AD
    Ir Med J; 2007 Apr; 100(4):422-4. PubMed ID: 17566474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sentinel node biopsy as a prognostic factor in cutaneous melanoma].
    Avilés-Izquierdo JA; Lázaro-Ochaita P
    Actas Dermosifiliogr; 2009; 100(6):486-92. PubMed ID: 19709553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of extent of ulceration in primary cutaneous melanoma.
    Grande Sarpa H; Reinke K; Shaikh L; Leong SP; Miller JR; Sagebiel RW; Kashani-Sabet M
    Am J Surg Pathol; 2006 Nov; 30(11):1396-400. PubMed ID: 17063079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
    J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma.
    Pearlman NW; McCarter MD; Frank M; Hurtubis C; Merkow RP; Franklin WA; Gonzalez R; Lewis K; Roaten JB; Robinson WA
    Am J Surg; 2006 Dec; 192(6):878-81. PubMed ID: 17161112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of metallothionein-overexpression with sentinel lymph node biopsy as prognostic factors in melanoma.
    Weinlich G; Topar G; Eisendle K; Fritsch PO; Zelger B
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):669-77. PubMed ID: 17447982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.